1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis

$1,503,461UH3FY2021HLNIH

Fred Hutchinson Cancer Center, Seattle WA

Investigators

Michael J Boeckhcontact Abhijit Prakash Limaye Gordon D Rubenfeld Renee D Stapleton

Linked publications & trials

Paper 38481427 Paper 37682870

View original record on NIH RePORTER →

1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and Sepsis · GrantIndex